Dr. Reddy's Laboratories Limited logo

Dr. Reddy's Laboratories Limited

RDY US

Dr. Reddy's Laboratories LimitedUSUnited States Composite

Company Description

CEO
Mr. Erez Israeli M.B.A., Mr. Deepak Sapra M.B.A., Mr. Venkata Ramana Motupalli M.B.A., Mr. Marc Kikuchi B.A., M.B.A., Mr. Patrick Aghanian B.A., M.B.A.
Full Time Employees
25,863
Sector
Healthcare
Industry
Drug Manufacturers—Specialty & Generic
Address
8-2-337, Road No. 3 Hyderabad India 500034
Business
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segments. The company's Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations. This segment also engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. This segment also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids in accordance with the specific customer requirements. The Others segment engages in developing therapies in the fields of oncology and inflammation; research and development of differentiated formulations; and provides digital healthcare and information technology enabled business support services. The therapeutic categories primarily include gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology. Dr. Reddy's Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.

Company News

  • Dr Reddy's Labs 1Q Rev $821M >RDY

  • Dr Reddy's Labs 4Q EPS 70c >RDY

  • The success of Merck's antiviral — and other COVID-19 pills in development — may depend on how quickly people start taking them